• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[原发性肾小球疾病中特定促细胞分裂剂对人淋巴因子的体外产生]

[In vitro production of a human lymphokine by a specific mitogen in primary glomerular nephropathies].

作者信息

Laurent J, Heslan J M, Branellec A, Lagrue G

出版信息

Ann Biol Clin (Paris). 1984;42(3):207-10.

PMID:6476490
Abstract

Con A stimulated lymphocytes from some patients with primary glomerular disease release in vitro a lymphokine, the vascular permeability factor (VPF). House dust sensitization was early reported among these patients. We therefore studied the action of this specific mitogen on VPF production in 58 patients with primary glomerular disease, whose 23 chosen because cutaneous house dust sensitivity. For the whole patients, house dust and Con A induced VPF production were statistically equivalent and both higher than that of unstimulated lymphocytes. Lymphocytes from the 23 house dust sensitised patients, stimulated by the allergen, produced more VPF than lymphocytes from unsensitised patients.

摘要

刀豆蛋白A刺激一些原发性肾小球疾病患者的淋巴细胞在体外释放一种淋巴因子,即血管通透性因子(VPF)。这些患者中早期就有报道对屋尘敏感。因此,我们研究了这种特异性促细胞分裂剂对58例原发性肾小球疾病患者VPF产生的作用,其中23例因对屋尘皮肤过敏而入选。对于所有患者,屋尘和刀豆蛋白A诱导的VPF产生在统计学上相当,且均高于未刺激的淋巴细胞。23例对屋尘敏感患者的淋巴细胞在变应原刺激下产生的VPF比未致敏患者的淋巴细胞更多。

相似文献

1
[In vitro production of a human lymphokine by a specific mitogen in primary glomerular nephropathies].[原发性肾小球疾病中特定促细胞分裂剂对人淋巴因子的体外产生]
Ann Biol Clin (Paris). 1984;42(3):207-10.
2
Studies of glomerular permeability factor (GPF) in focal segmental glomerular sclerosis and the relationship between GPF and vascular permeability factor (VPF).局灶节段性肾小球硬化中肾小球通透因子(GPF)的研究以及GPF与血管通透因子(VPF)之间的关系。
Clin Nephrol. 1999 Nov;52(5):278-84.
3
Interleukin-15 and interleukin-12 have an additive effect on the release of vascular permeability factor by peripheral blood mononuclear cells in normals and in patients with nephrotic syndrome.白细胞介素-15和白细胞介素-12对正常人和肾病综合征患者外周血单个核细胞释放血管通透性因子具有相加作用。
Clin Nephrol. 1999 Jul;52(1):10-8.
4
Transforming growth factor-beta1 inhibits vascular permeability factor release by T cells in normal subjects and in patients with minimal-change nephrotic syndrome.转化生长因子-β1抑制正常受试者和微小病变型肾病综合征患者T细胞释放血管通透性因子。
Nephron. 2001 Feb;87(2):111-7. doi: 10.1159/000045898.
5
Vascular permeability increasing factor (VPF) in IgA nephropathy.
Clin Nephrol. 1982 Oct;18(4):165-7.
6
Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract.血管通透因子(血管内皮生长因子)及其受体在胃肠道腺癌中的表达
Cancer Res. 1993 Oct 1;53(19):4727-35.
7
Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries.正常及动脉粥样硬化人动脉中的血管内皮生长因子/血管通透因子(VEGF/VPF)
Am J Pathol. 1997 May;150(5):1673-85.
8
Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms.血管通透性因子(血管内皮生长因子)及其受体在卵巢交界性肿瘤和恶性肿瘤中的强表达。
Lab Invest. 1996 Jun;74(6):1105-15.
9
Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.通过抑制血管内皮生长因子受体酪氨酸激酶磷酸化治疗人肺腺癌恶性胸腔积液
Clin Cancer Res. 2000 Mar;6(3):957-65.
10
Physicochemical characterization of a vascular permeability factor produced by con A-stimulated human lymphocytes.伴刀豆球蛋白A刺激的人淋巴细胞产生的血管通透性因子的物理化学特性
J Immunol. 1977 Oct;119(4):1230-4.